These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 13983278)

  • 1. Monoamine oxidase and the function of the central nervous system.
    RYSANEK K; VITEK V; SMAHEL O
    Act Nerv Super (Praha); 1962 Sep; 4():427-30. PubMed ID: 13983278
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure of rat monoamine oxidase A and its specific recognitions for substrates and inhibitors.
    Ma J; Yoshimura M; Yamashita E; Nakagawa A; Ito A; Tsukihara T
    J Mol Biol; 2004 Apr; 338(1):103-14. PubMed ID: 15050826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical experiences with monoamine oxidase inhibitors and other substances controlling serotonin metabolism].
    CONSBRUCH U; FAUST C
    Psychiatr Neurol (Basel); 1960 Jul; 140():76-82. PubMed ID: 13695106
    [No Abstract]   [Full Text] [Related]  

  • 4. MAO ACTIVITY IN RELATION TO DEPRESSION.
    FELDSTEIN A; HOAGLAND H; WONG KK; OKTEM MR; FREEMAN H
    Am J Psychiatry; 1964 Jun; 120():1192-4. PubMed ID: 14154756
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterisation of imidazoline I2 binding sites in pig brain.
    Anderson NJ; Lupo PA; Nutt DJ; Hudson AL; Robinson ES
    Eur J Pharmacol; 2005 Sep; 519(1-2):68-74. PubMed ID: 16109401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ecstasy-induced oxidative stress to adolescent rat brain mitochondria in vivo: influence of monoamine oxidase type A.
    Alves E; Summavielle T; Alves CJ; Custódio JB; Fernandes E; de Lourdes Bastos M; Tavares MA; Carvalho F
    Addict Biol; 2009 Apr; 14(2):185-93. PubMed ID: 19076925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A CONTRIBUTION ON MONOAMINE OXIDASE IN THE CENTRAL NERVOUS SYSTEM].
    WOOHSMANN H
    Acta Biol Med Ger; 1963; 11():164-8. PubMed ID: 14059226
    [No Abstract]   [Full Text] [Related]  

  • 8. [THE BEHAVIOR OF BRAIN ENZYMES IN DISEASES OF THE EXTRAPYRAMIDAL MOTOR SYSTEM].
    HARTMANN-VONMONAKOW K
    Schweiz Arch Neurol Neurochir Psychiatr; 1963; 92():415-6. PubMed ID: 14059163
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion.
    Gal S; Zheng H; Fridkin M; Youdim MB
    J Neurochem; 2005 Oct; 95(1):79-88. PubMed ID: 16181414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Urinary excretion of 5-hydroxyindolacetic acid (5-HIAA) in 150 patients with depressive syndrome and maniacal agitation. (Its modifications by 5-hydroxy-tryptophan loading and therapy in the depressive states)].
    BURGERMEISTER JJ; DICK P; GARONNE G; GUGGISBERG M; TISSOT R
    Presse Med (1893); 1963 May; 71():1116-8. PubMed ID: 14016979
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative study of catalytic properties of mink and rat liver monoamine oxidase].
    Iagodina OV
    Zh Evol Biokhim Fiziol; 2008; 44(6):570-6. PubMed ID: 19198157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contribution to the study of the mechanism of antidepressive action of monoamine oxidase inhibitors (MAOI) at the level of the central nervous system in the mouse. II. Influence of some pyridoxine derivatives on the antidepressive action of MAOI].
    DENYS A; LEVY J; MICHEL-BER E
    J Physiol (Paris); 1963; 55():381-404. PubMed ID: 14027058
    [No Abstract]   [Full Text] [Related]  

  • 13. High-throughput screening for monoamine oxidase-A and monoamine oxidase-B inhibitors using one-step fluorescence assay.
    Guang HM; Du GH
    Acta Pharmacol Sin; 2006 Jun; 27(6):760-6. PubMed ID: 16723097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interaction between monoamine oxidase inhibitors and psychotomimetic drugs].
    CAZZULLO CL; GOLDWURM GF
    Rass Studi Psichiatr; 1962; 51():979-93. PubMed ID: 14019547
    [No Abstract]   [Full Text] [Related]  

  • 15. Serotonin toxicity associated with the use of linezolid: a review of postmarketing data.
    Lawrence KR; Adra M; Gillman PK
    Clin Infect Dis; 2006 Jun; 42(11):1578-83. PubMed ID: 16652315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of a monoamine oxidase B selective inhibitor from tobacco smoke.
    Khalil AA; Davies B; Castagnoli N
    Bioorg Med Chem; 2006 May; 14(10):3392-8. PubMed ID: 16458520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of some substances on neuroregulatory mechanism.
    RYSANEK K; SMAHEL O; SMAHELOVA R; VITEK V; VOJTECHOVSKY M
    Act Nerv Super (Praha); 1962 Sep; 4():422-6. PubMed ID: 13983277
    [No Abstract]   [Full Text] [Related]  

  • 18. CONCEPT OF THE NEUROCHEMICAL TRANSDUCER AS AN ORGANIZED MOLECULAR UNIT AT SYMPATHETIC NERVE ENDINGS.
    BRODIE BB; COSTA E
    Act Nerv Super (Praha); 1963 Jul; 5():264-79. PubMed ID: 14055185
    [No Abstract]   [Full Text] [Related]  

  • 19. [Inhibition of monamine oxidase activity by substituted azetidines].
    SCHIATTI P; SELVA D
    Boll Soc Ital Biol Sper; 1961 Dec; 37():1432-6. PubMed ID: 13991650
    [No Abstract]   [Full Text] [Related]  

  • 20. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
    Youdim MB; Fridkin M; Zheng H
    Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.